Related references
Note: Only part of the references are listed.Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus
Gregor Ebert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Inhibitors of apoptosis proteins (IAPs) are required for effective T-cell expansion/survival during antiviral immunity in mice
Ian E. Gentle et al.
BLOOD (2014)
Birinapant, a Smac-Mimetic with Improved Tolerability for the Treatment of Solid Tumors and Hematological Malignancies
Stephen M. Condon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synergistic Targeting of AML Stem/Progenitor Cells With IAP Antagonist Birinapant and Demethylating Agents
Bing Z. Carter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF-kB Activation, and Is Active in Patient-Derived Xenograft Models
Christopher A. Benetatos et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism
Jennifer L. Allensworth et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells
Clemens Krepler et al.
CLINICAL CANCER RESEARCH (2013)
Smac-Mimetic-Induced Epithelial Cell Death Reduces the Growth of Renal Cysts
Lucy X. Fan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Elizabeth B. Wilson et al.
SCIENCE (2013)
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
John R. Teijaro et al.
SCIENCE (2013)
T-cell responses in hepatitis B and C virus infection: similarities and differences
Julia Schmidt et al.
EMERGING MICROBES & INFECTIONS (2013)
Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy
Joung-Liang Lan et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
The regulation of TNF signalling: what a tangled web we weave
John Silke
CURRENT OPINION IN IMMUNOLOGY (2011)
IAP inhibitors enhance co-stimulation to promote tumor immunity
Michael Dougan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Immune effectors required for hepatitis B virus clearance
Priscilla L. Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model
Yi-Jiun Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TNF-α induces two distinct caspase-8 activation pathways
Lai Wang et al.
CELL (2008)
IAP antagonists target cIAP1 to induce TNFα- dependent apoptosis
James E. Vince et al.
CELL (2007)
Autocrine TNFα signaling renders human cancer cells susceptible to smac-mimetic-induced apoptosis
Sean L. Petersen et al.
CANCER CELL (2007)
An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection
Li-Rung Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The immune response during hepatitis B virus infection
Antonio Bertoletti et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Boosting immunity by antiviral drug therapy: A simple relationship among timing, efficacy, and success
NL Komarova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
